Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis-Reference-Cited by-同舟云学术

Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

Published:2022-11 Issue: Volume:844 Page:146829
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Shomali Navid,Baradaran Behzad,Daei Sorkhabi Amin,Sarkesh Aila,Kahrizi Mohammad Saeed,Tosan Foad,Mahmoodpoor Ata,Mardi Amirhossein,Mohammadi Hamed,Hassanzadeh Ali,Saeedi Hossein,Hajialilo Mehrzad,Hemmatzadeh Maryam,Marofi Faroogh,Sandoghchian Shotorbani Siamak

Funder

Tabriz University of Medical Sciences

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference48 articles.

1. Serum levels of Survivin in patients with psoriasis and their relation to disease characteristics;Akpinar;J. Cosmet. Dermatol.,2022

2. Alizadeh-Fanalou, S., Alian, F., Mohammadhosayni, M., Rahban, D., Abbasi Ghasem Kheyli, P. and Ahmadi, M., 2020. Dysregulation of microRNAs regulating Survivin in CD4+ T cells in multiple sclerosis. Mult Scler Relat. Disord., 44, 102303.

3. Inflammation-associated cell cycle-independent block of apoptosis by Survivin in terminally differentiated neutrophils;Altznauer;J. Exp. Med.,2004

4. The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates;Babaie;Immunol. Lett.,2018

5. MicroRNAs: The Role in Autoimmune Inflammation;Baulina;Acta Naturae,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice;Cell Communication and Signaling;2023-11-09

2. Molecular mechanisms of long non-coding RNAs in differentiation of T Helper17 cells;International Immunopharmacology;2023-10

3. Gastric cancer combination therapy by siRNA-mediated NFE2L2(NRF2) silencing and paclitaxel;2023-08-31

4. Gastric cancer combination therapy by siRNA-mediated NRF2 silencing and paclitaxel;2023-06-28

5. The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies;Frontiers in Immunology;2023-03-20